Pillstats
Rx only · Emulsion · Ophthalmic

Difluprednate

Brands: Durezol · Difluprednate

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)23043
US makers6 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$4.54$9.08$13.62$18.16Dec 2025Apr 2026Jul 2026
$13.617
Latest avg · Jul 22, 2026
-13%
Since Dec 17, 2025
6
Active US suppliers
33%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

7471.5K2.2K3.0K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.6K
Rx · 2026 Q1
14K
Units dispensed
+1446%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Sandoz Incunknown1SUPPLYING
Upsher-Smith Laboratories, LLCunknown1SUPPLYING
Mylan Pharmaceuticals Inc.unknown1SUPPLYING
Caplin Steriles Limitedunknown1SUPPLYING
Cipla USA Inc.unknown1SUPPLYING
Leading Pharma, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Aug 22, 2022
    RECALLRecall (Class II): Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured by Cipla Ltd., India, Manufactured for: Ci…

    Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility. — Recalling firm: CIPLA — Nationwide in the USA

  • Aug 2, 2022
    RECALLRecall (Class II): Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., In…

    Lack of Assurance of Sterility: Complaints received of defective container closure. — Recalling firm: CIPLA — Nationwide in the USA

  • Jul 14, 2022
    RECALLRecall (Class II): Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S Indoco Remedies Limit…

    Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility. — Recalling firm: CIPLA — Nationwide in the USA